Pricing
Baxiva is developing the first K-antigen-targeting vaccine to prevent E. coli infections, offering the highest level of protection against UTIs and systemic infections.
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (5)
Unverified
This company has no teams yet
This company has no offices yet